Boehringer_Workplace_Lab_Research
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
July 18, 2024 03:05 ET | Boehringer Ingelheim
Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncologyFurther data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosisStrong first half net sales...
22157.jpg
Survey Results of 830+ Patient Groups on the Pharmaceutical Industry and Environmental, Social, and Governance (ESG) Practices
June 24, 2024 11:44 ET | Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World" report has been added to ...
1nHealth and The Mighty
1nHealth Partners With The Mighty to Bring Fresh Patient Centricity to Clinical Trial Recruitment
February 01, 2023 10:30 ET | 1nHealth
ORLANDO, Fla., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Clinical trials bring hope to patients by exposing them to potentially groundbreaking therapies. Thus, it can be especially devastating for patients...
Chart 5 The Pharma Companies Rising the Most in the Italy Rankings, 2020 to 2021
The Views of 103 Italian Patient Groups on the Corporate Reputation of Pharma, 2021-2022: Roche Ranked 1st Overall with Novo Nordisk in 2nd and Pfizer in 3rd
January 12, 2023 08:53 ET | Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups" report has been added to...
Pharma Companies Ranking For ESG - Perspective of Patient Groups Familiar with the Company
Survey of 1,500 Patient Groups on the Pharmaceutical Industry and ESG (Environmental, Social, and Governance) - Rankings of a Company's Effectiveness at Adopting and Communicating their ESG Agendas
December 09, 2022 07:08 ET | Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Pharma and ESG - The Patient Perspective - The Views of 1,500 Patient Groups" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
Global $10.52 Billion Pharma & Biotech CRM Software Markets Analysis & Forecasts, 2016-2020 & 2021-2027
September 22, 2021 07:08 ET | Research and Markets
Dublin, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The "Global CRM Software for Pharma & Biotech Market, By Deployment, By Enterprise Size, By Industry, By Region, Estimation & Forecast, 2017 -...
22157.jpg
US Patient Perspective of the Corporate Reputation of Pharma in 2020 During the COVID-19 Pandemic Covering 64 Main Medical Specialties
June 25, 2021 04:23 ET | Research and Markets
Dublin, June 25, 2021 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2020 during the Covid Pandemic - the US Patient Perspective" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Corporate Reputation of Pharma in 2020 During the Covid Pandemic: Respondent Patient Groups Reached Out to More Than 1 Million Patients in 2020
June 08, 2021 04:33 ET | Research and Markets
Dublin, June 08, 2021 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2020 during the Covid Pandemic - Global Edition" report has been added to ResearchAndMarkets.com's offering. ...
InspireLogo_Together_July2016.jpg
Inspire Insights: A powerful data platform enabling pharma researchers to achieve patient-focused drug development
October 31, 2018 07:00 ET | Inspire
ARLINGTON, Va., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Life sciences companies can now gain a deeper understanding of patients across the drug development lifecycle through new solutions that Inspire...
The Top 3 Pharma Functions Involved in Patient-Centric Initiatives (Apart from Marketing)
July 31, 2017 16:44 ET | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 31, 2017) - Apart from marketing, the most popular functions that are involved in at least 65% of surveyed patient-centric initiatives are brand team,...